CSBR Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:00):

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States...

Stats
Tagesvolumen	4 626.00
Durchschnittsvolumen	3 990.00
Marktkapitalisierung	66.88M
EPS	$-0.160 ( 2024-03-20 )
Nächstes Ertragsdatum	( $-0.160 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.83
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-09	Davis Brady	Buy	68 000	Option to purchase Common Stock
2023-10-09	Davis Brady	Buy	7 500	Option to purchase Common Stock
2023-10-09	Davis Brady	Buy	135 000	Option to purchase Common Stock
2024-01-12	Mendelson Daniel Newman	Buy	1 000	Common Stock
2024-01-11	Mendelson Daniel Newman	Buy	2 000	Common Stock

INSIDER POWER
88.92
Last 100 transactions
Buy: 1 237 465 \| Sell: 480 213

Champions Oncology Inc Korrelation

10 Am meisten positiv korreliert
VCSA	0.965
OPTN	0.965
AGZD	0.957
STSA	0.955
TOI	0.945
IMRX	0.94
ONCS	0.94
ADSE	0.933
TCDA	0.931
VSTA	0.93

10 Am meisten negativ korreliert
ARNA	-0.953
CCRC	-0.938
PBFS	-0.922
MACK	-0.917
APEN	-0.912
IBEX	-0.91
CLRO	-0.907
IMMR	-0.905
STIM	-0.899
SEDG	-0.896

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Champions Oncology Inc Finanzdaten

Annual	2023
Umsatz:	$53.87M
Bruttogewinn:	$24.34M (45.18 %)
EPS:	$-0.390

FY	2023
Umsatz:	$53.87M
Bruttogewinn:	$24.34M (45.18 %)
EPS:	$-0.390

FY	2022
Umsatz:	$49.11M
Bruttogewinn:	$25.48M (51.88 %)
EPS:	$0.0415

FY	2021
Umsatz:	$41.04M
Bruttogewinn:	$19.59M (47.74 %)
EPS:	$0.0300

Financial Reports:

No articles found.

Champions Oncology Inc

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.